Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 2010 Oct; 59(10):1401-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.